Mild injection-site reactions affect approximately 5-10 percent of recipients, while systemic effects are less frequent but warrant careful monitoring
A job interview, wedding, or other important event coming up might warrant pausing treatment until a less critical time
Bioavailability Topical GHK-Cu achieves good local bioavailability in the skin but minimal systemic absorption
Each 2mg injection contributes approximately 0.03mg copper, compared to 0.9-2.2mg from typical daily diet
Q&A with John Bothmer, Clinical Translation Medicine Fellow at Angelini Pharma To further explore the scientific, regulatory and operational complexity behind FirstinHuman trials , we spoke with John Bothmer, Clinical Translation Medicine Fellow within the Global Clinical Development & Clinical Operations department at Angelini Pharma , about the role these studies play in clinical development and the safeguards that support this transition from preclinical research to human investigation